Rockefeller Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
151,164
+54,574
+57% +$3.1M 0.02% 718
2026
Q1
$6.2M Buy
96,590
+96,028
+17,087% +$8.76M 0.01% 841
2025
Q4
$73.1K Buy
562
+62
+12% +$8.51K ﹤0.01% 2882
2025
Q3
$53.9K Buy
+500
New +$54.5K ﹤0.01% 2871
2021
Q4
Sell
-785
Closed -$196K 4006
2021
Q3
$196K Buy
+785
New +$270K ﹤0.01% 1591

Other funds holding WGS

Rockefeller Capital Management's WGS Position: Q2 2026 in Review

Rockefeller Capital Management increased its GeneDx Holdings (WGS) stake by 57% in Q2 2026, buying an estimated $3.1M and bringing the position to 151,164 shares worth $10.4M. The position accounts for 0.02% of the portfolio, ranked #718.

Rockefeller Capital Management first reported a position in WGS in Q3 2021 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Rockefeller Capital Management held 151,164 shares of GeneDx Holdings worth $10.4M as of Q2 2026.
  • Rockefeller Capital Management bought 54,574 GeneDx Holdings shares in Q2 2026, an estimated $3.1M.
  • GeneDx Holdings made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #718 holding.
  • Rockefeller Capital Management first reported a position in GeneDx Holdings in Q3 2021 and has held it in 5 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.